After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRGX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of CARGO Therapeutics Inc is $189.73M. A total of 1.32 million shares were traded on the day, compared to an average of 1.11M shares.
In the most recent transaction, Chapman Gina sold 7,166 shares of CRGX for 25.09 per share on Sep 18 ’24. After the transaction, the President & CEO now owns 103,905 company shares. In a previous transaction on Sep 19 ’24, Chapman Gina sold 2,975 shares at 25.03 per share. CRGX shares that President & CEO owns now total 103,905.
Among the insiders who sold shares, Radhakrishnan Anup disposed of 1,600 shares on Sep 18 ’24 at a per-share price of $25.28. This resulted in the Chief Financial Officer holding 6,446 shares of CRGX after the transaction. In another insider transaction, ANUP RADHAKRISHNAN bought 14,000 shares at $23.33 per share on Sep 18 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRGX has a high of $25.45 and a low of $3.00.
As of this writing, CRGX has an earnings estimate of -$0.57 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.73.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRGX’s latest balance sheet shows that the firm has $41.00k in Cash & Short Term Investments as of fiscal 2021. There were $3.17M in debt and $2.45M in liabilities at the time. Its Book Value Per Share was $7.82, while its Total Shareholder’s Equity was -$175.00k.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRGX is Buy with a score of 2.60.
